St. Charles Targets Esophageal Cancer with New, Cutting Edge Tool
Gastroenterologists at St. Charles are among a handful on Long Island using the Barrx™ radiofrequency ablation system, a new, cutting-edge tool for removing cancerous, precancerous and diseased tissue from the esophagus, which can develop due to regular, long-term exposure to acid reflux, or GERD. Heartburn is a commonly reported symptom of GERD.
St. Charles physicians are specially trained in using the Barrx™ tool to precisely isolate and capture abnormal esophageal tissue while sparing surrounding healthy tissue.
Radiofrequency ablation is part of a non-surgical procedure testing for cancer and for Barrett’s esophagus, a condition in which tissue of the esophagus has been altered by GERD. Barrett’s esophagus increases the risk for developing esophageal cancer.
While only a small percentage of those with Barrett’s esophagus go on to develop cancer, esophageal cancer carries a 43% - 5% survival rate post-diagnosis, depending on stage.
Experts recommend that those living with heartburn, acid reflux or GERD see a gastroenterologist regularly.
To make an appointment with a gastroenterologist at St. Charles, please call (631) 474-6797.